Carol Dangelmaier

3.7k total citations
89 papers, 3.1k citations indexed

About

Carol Dangelmaier is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Carol Dangelmaier has authored 89 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hematology, 26 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Carol Dangelmaier's work include Platelet Disorders and Treatments (62 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Carol Dangelmaier is often cited by papers focused on Platelet Disorders and Treatments (62 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers). Carol Dangelmaier collaborates with scholars based in United States, Germany and Norway. Carol Dangelmaier's co-authors include James L. Daniel, J. Bryan Smith, Holm Holmsen, Satya P. Kunapuli, Jianguo Jin, Barrie Ashby, Gérard Mauco, Mary Selak, Bhanu Kanth Manne and Jun‐Jang Jin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Carol Dangelmaier

87 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carol Dangelmaier United States 33 1.4k 1.0k 718 448 404 89 3.1k
S Lévy-Toledano France 38 1.6k 1.1× 1.5k 1.4× 660 0.9× 318 0.7× 359 0.9× 135 4.1k
Minoru Okuma Japan 30 1.2k 0.9× 935 0.9× 392 0.5× 527 1.2× 274 0.7× 116 3.3k
Jean‐Philippe Rosa France 28 1.4k 1.0× 824 0.8× 358 0.5× 307 0.7× 249 0.6× 64 2.7k
Bahjat Al‐Ani Saudi Arabia 30 1.4k 1.0× 816 0.8× 321 0.4× 646 1.4× 1.1k 2.7× 94 3.4k
Mahmoud Saifeddine Canada 34 2.0k 1.4× 739 0.7× 391 0.5× 512 1.1× 1.5k 3.6× 66 3.2k
Thomas C. Detwiler United States 32 1.4k 1.0× 917 0.9× 448 0.6× 141 0.3× 407 1.0× 69 3.0k
Franck Peiretti France 31 363 0.3× 1.5k 1.4× 326 0.5× 604 1.3× 123 0.3× 82 3.6k
David W. Essex United States 30 655 0.5× 582 0.6× 124 0.2× 525 1.2× 196 0.5× 58 2.5k
Ilaria Canobbio Italy 27 745 0.5× 614 0.6× 342 0.5× 242 0.5× 143 0.4× 57 1.9k
Clement A. Diglio United States 38 392 0.3× 1.6k 1.5× 342 0.5× 408 0.9× 179 0.4× 100 3.5k

Countries citing papers authored by Carol Dangelmaier

Since Specialization
Citations

This map shows the geographic impact of Carol Dangelmaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Dangelmaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Dangelmaier more than expected).

Fields of papers citing papers by Carol Dangelmaier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Dangelmaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Dangelmaier. The network helps show where Carol Dangelmaier may publish in the future.

Co-authorship network of co-authors of Carol Dangelmaier

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Dangelmaier. A scholar is included among the top collaborators of Carol Dangelmaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Dangelmaier. Carol Dangelmaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dangelmaier, Carol, et al.. (2024). Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets. Platelets. 35(1). 2369766–2369766. 1 indexed citations
3.
Dangelmaier, Carol, et al.. (2022). Clustering extent‐dependent differential signaling by CLEC‐2 receptors in platelets. Research and Practice in Thrombosis and Haemostasis. 6(3). e12710–e12710. 6 indexed citations
4.
Kostyak, John C., Carol Dangelmaier, Yuhang Zhou, et al.. (2017). TULA-2 Deficiency Enhances Platelet Response to CLEC-2 Agonists. Blood. 130. 2302–2302. 1 indexed citations
5.
Manne, Bhanu Kanth, Todd M. Getz, Craig E. Hughes, et al.. (2013). Fucoidan Is a Novel Platelet Agonist for the C-type Lectin-like Receptor 2 (CLEC-2). Journal of Biological Chemistry. 288(11). 7717–7726. 61 indexed citations
6.
Kim, Soochong, Carol Dangelmaier, Dheeraj Bhavanasi, et al.. (2013). RhoG Protein Regulates Glycoprotein VI-Fc Receptor γ-Chain Complex-mediated Platelet Activation and Thrombus Formation. Journal of Biological Chemistry. 288(47). 34230–34238. 18 indexed citations
7.
Thomas, Dafydd, Todd M. Getz, Tiffanny Newman, et al.. (2010). A novel histidine tyrosine phosphatase, TULA-2, associates with Syk and negatively regulates GPVI signaling in platelets. Blood. 116(14). 2570–2578. 54 indexed citations
8.
Kim, Soochong, Pierre Mangin, Carol Dangelmaier, et al.. (2009). Role of Phosphoinositide 3-Kinase β in Glycoprotein VI-mediated Akt Activation in Platelets. Journal of Biological Chemistry. 284(49). 33763–33772. 107 indexed citations
9.
Dangelmaier, Carol, et al.. (2007). Glycoprotein VI agonists have distinct dependences on the lipid raft environment. Journal of Thrombosis and Haemostasis. 5(2). 362–368. 15 indexed citations
10.
Özdener, Fatih, Carol Dangelmaier, Barrie Ashby, Satya P. Kunapuli, & James L. Daniel. (2002). Activation of Phospholipase Cγ2 by Tyrosine Phosphorylation. Molecular Pharmacology. 62(3). 672–679. 52 indexed citations
11.
Daniel, James L., et al.. (1999). Role of Intracellular Signaling Events in ADP-induced Platelet Aggregation. Thrombosis and Haemostasis. 82(10). 1322–1326. 95 indexed citations
12.
Daniel, James L., Carol Dangelmaier, Jianguo Jin, et al.. (1998). Molecular Basis for ADP-induced Platelet Activation. Journal of Biological Chemistry. 273(4). 2024–2029. 374 indexed citations
13.
Smith, J. Bryan, Carol Dangelmaier, Mary Selak, & James L. Daniel. (1991). Facile platelet adhesion to collagen requires metabolic energy and actin polymerization and evokes intracellular free calcium mobilization. Journal of Cellular Biochemistry. 47(1). 54–61. 19 indexed citations
14.
Smith, J. Bryan, Carol Dangelmaier, & Mary Selak. (1991). Identification of 50 kDa snake venom proteins which specifically inhibit platelet adhesion to collagen. FEBS Letters. 283(2). 307–310. 23 indexed citations
15.
Smith, J. Bryan & Carol Dangelmaier. (1990). Determination of platelet adhesion to collagen and the associated formation of phosphatidic acid and calcium mobilization. Analytical Biochemistry. 187(1). 173–178. 25 indexed citations
16.
Lages, Bruce, Carol Dangelmaier, Holm Holmsen, & H J Weiss. (1988). Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate.. Journal of Clinical Investigation. 81(6). 1865–1872. 14 indexed citations
17.
Daniel, James L., Carol Dangelmaier, Mary Selak, & J. Bryan Smith. (1986). ADP stimulates IP3 formation in human platelets. FEBS Letters. 206(2). 299–303. 66 indexed citations
18.
Smith, J. Bryan, Carol Dangelmaier, A. David Purdon, & Gérard Mauco. (1985). Regulation of Platelet Phospholipid Metabolism. Advances in experimental medicine and biology. 192. 281–291. 2 indexed citations
20.
Dangelmaier, Carol & Holm Holmsen. (1980). Determination of acid hydrolases in human platelets. Analytical Biochemistry. 104(1). 182–191. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026